2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trialIan Smith, Martine Piccart, Gabriella Mariani et al.|The Lancet|2007Cited by 1.5k
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trialOliver Sartor, Christopher Parker, Robert L. Coleman et al.|The Lancet Oncology|2014Cited by 491
Endometrial carcinosarcomaGiorgio Bogani, Bradley J. Monk, Isabelle Ray‐Coquard et al.|International Journal of Gynecological Cancer|2022Cited by 95
OBESITY, PHYSICAL INACTIVITY AND SYMPTOMS AFTER OVARIAN CANCER TREATMENT: RESULTS FROM AN INTERNATIONAL INTERNET-BASED SURVEYKate Webber, Michael Friedländer, D. Sommeijer et al.|International Journal of Gynecological Cancer|2015Cited by 1